Association between interleukin 23 receptor polymorphism and kidney transplant outcomes: A 10-year Taiwan cohort study

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 958-962

  Tsai, Jen Pi ^a,b   Yang, Shun Fa ^a   Wu, Sheng Wen ^a,c   Hung, Tung Wei ^a,c   Tsai, Hui Ching ^c   Lian, Jong Da ^a,c   Chang, Horng Rong ^a,c  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Biopsy proven acute rejection; Gene polymorphism; IL 23R; Interstitial fibrosis and or tubular atrophy; Renal transplantation

Indexed keywords

ALANINE; CREATININE; INTERLEUKIN 23 RECEPTOR;

ACUTE GRAFT REJECTION; ADULT; ALLELE; ARTICLE; ATROPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FIBROSING ALVEOLITIS; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; IMMUNOMODULATION; KIDNEY BIOPSY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TAIWAN;

ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN; TAIWAN; TREATMENT OUTCOME;

EID: 79954988506     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.01.031     Document Type: Article

References (27)

1. Meier-Kriesche H.U., Schold J.D., Srinivas T.R., Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004, 4:378-383.
2. Chapman J.R., O'Connell P.J., Nankivell B.J. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005, 16:3015-3026.
3. Schwarz A., Mengel M., Gwinner W., et al. Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int 2005, 67:341-348.
4. Alakulppi N.S., Kyllonen L.E., Jantti V.T., et al. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation 2004, 78:1422-1428.
5. Hoffmann S., Park J., Jacobson L.M., et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 2004, 66:1686-1693.
6. Pawlik A., Domanski L., Rozanski J., et al. The cytokine gene polymorphisms in patients with chronic kidney graft rejection. Transpl Immunol 2005, 14:49-52.
7. Satoh S., Saito M., Inoue K., Miura M., Komatsuda A., Habuchi T. Association of cytokine polymorphisms with subclinical progressive chronic allograft nephropathy in Japanese renal transplant recipients: preliminary study. Int J Urol 2007, 14:990-994.
8. Thakkinstian A., Dmitrienko S., Gerbase-Delima M., et al. Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrol Dial Transplant 2008, 23:3017-3023.
9. Trinchieri G., Pflanz S., Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644.
10. Markey K.A., MacDonald K.P., Hill G.R. Impact of cytokine gene polymorphisms on graft-vs-host disease. Tissue Antigens 2008, 72:507-516.
11. Elmaagacli A.H., Koldehoff M., Landt O., Beelen D.W. Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Bone Marrow Transplant 2008, 41:821-826.
12. Duerr R.H., Taylor K.D., Brant S.R., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
13. Huber A.K., Jacobson E.M., Jazdzewski K., Concepcion E.S., Tomer Y. Interleukin (IL)-23 receptor is a major susceptibility gene for Graves' ophthalmopathy: the IL-23/T-helper 17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 2008, 93:1077-1081.
14. Farago B., Magyari L., Safrany E., et al. Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis 2008, 67:248-250.
15. Fellstrom B., Holdaas H., Jardine A.G., et al. Risk factors for reaching renal endpoints in the assessment of Lescol in renal transplantation (ALERT) trial. Transplantation 2005, 79:205-212.
16. Knoll G.A., Cantarovitch M., Cole E., et al. The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation - study design. Nephrol Dial Transplant 2008, 23:354-358.
17. Solez K., Colvin R.B., Racusen L.C., et al. Banff '05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007, 7:518-526.
18. Ban Y., Tozaki T., Taniyama M., Nakano Y., Yoneyama K., Hirano T. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 2009, 42:126-130.
19. Li Y., Liang W.B., Li C., et al. The association between interleukin-23 receptor gene polymorphisms and systemic lupus erythematosus. DNA Cell Biol 2010, 29:79-82.
20. Chen Y., Zhou B., Peng Y., et al. Interleukin-23 receptor gene polymorphisms is associated with dilated cardiomyopathy in Chinese Han population. Tissue Antigens 2009, 73:330-334.
21. Vanden Eijnden S., Goriely S., De Wit D., Willems F., Goldman M. IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur J Immunol 2005, 35:469-475.
22. Lankford C.S., Frucht D.M. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003, 73:49-56.
23. Langrish C.L., Chen Y., Blumenschein W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
24. McKenzie B.S., Kastelein R.A., Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006, 27:17-23.
25. Chu C.Q., Wittmer S., Dalton D.K. Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J Exp Med 2000, 192:123-128.
26. Kamoun M. Cellular and molecular parameters in human renal allograft rejection. Clin Biochem 2001, 34:29-34.
27. Kruger B., Schroppel B., Murphy B.T. Genetic polymorphisms and the fate of the transplanted organ. Transplant Rev (Orlando) 2008, 22:131-140.